Taishi Wada1, Hiroshi Doi1, Masaki Okubo1, Mikiko Tada1, Naohisa Ueda2, Wakana Tominaga1, Haruki Koike3, Kohei Hosoda1, Haruko Nakamura1, Keita Takahashi1, Misako Kunii1, Yosuke Miyaji1, Yuichi Higashiyama1, Satoko Miyatake4,5, Masahisa Katsuno3, Satoshi Fujii6, Naomichi Matsumoto4, Hideyuki Takeuchi1, Fumiaki Tanaka1 (1.Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan, 2.Department of Neurology, Yokohama City University Medical Center, Japan, 3.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 4.Department of Human Genetics, Yokohama City University Graduate School of Medicine, Japan, 5.Clinical Genetics Department, Yokohama City University Hospital, Japan, 6.Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Japan)
Session information
Oral Session
[O-15] Oral Session 15
Thu. Jun 1, 2023 9:45 AM - 10:45 AM Room5 (幕張メッセ国際会議場 3F 304)
Chair:Ishikawa Kinya (Personalized Genomic Medicine for Health, Japan)
Yuji Nishimura1, Katsuhisa Masaki1, Dai Matsuse1, Hiroo Yamaguchi1, Tatsunori Tanaka2, Shoko Sadashima3, Naokazu Sasagasako4, Ryo Yamasaki1, Hiroyuki Honda3, Noriko Isobe1, Toru Iwaki3, Jun-ichi Kira1,5,6 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Sumitomo Pharma, Japan, 3.Department of Neuropathology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 4.Department of Neurology, Neuro-Muscular Center, National Omuta Hospital, Fukuoka, Japan, 5.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 6.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, Japan)
Dai Matsuse1, Hiroo Yamaguchi1,2, Yuji Nishimura1, Katsuhisa Masaki1, Tatsunori Tanaka1, Toru Saiga1, Masaya Harada1, Kenji Tanaka3, Ryo Yamasaki1, Noriko Isobe1, Jun-ichi Kira1,4,5 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.School of Physical Therapy, Faculty of Rehabilitation, Reiwa Health Science University, Japan, 3.Department of Neuropsychiatry, School of Medicine, Keio University, Japan, 4.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 5.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, Japan)
Katsuhisa Masaki1, Yuji Nishimura1, Dai Matsuse1, Hiroo Yamaguchi1, Tatsunori Tanaka2, Shoko Sadashima1,3, Naokazu Sasagasako4, Ryo Yamasaki1, Toru Iwaki3, Noriko Isobe1, Junichi Kira1,5,6 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Sumitomo Pharma, Japan, 3.Department of Neuropathology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 4.Department of Neurology, Neuro-Muscular Center, National Omuta Hospital, Fukuoka, Japan, 5.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 6.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, Japan)